Happenings
Viewpoint Project: Future of Healthcare - Innovative solutions
July 27, 2023
News & Events
Stay Current!
Integral to your Xentria journey is being informed about developments that matter to you.
Bookmark and visit this page to stay up to date.
- All Posts
- Happenings
- Events
- Products
- Insider Xentria
Inside Xentria
Xentria’s Feature in Nature Biopharma Dealmakers
July 11, 2023
Inside Xentria
Licensing Agreement to Commercialize XTMAB-16 in Sarcoidosis
June 27, 2023
Events
ATS 2023: Join Us at our Clinical Trial Awareness Booth CT14 Hall D
May 2023
Happenings
Xentria Announces Peer Reviewed Publication of Biosim Model in Front. Pharmacol.
March 21, 2023
Products
Xentria Announces $25 Million Financing Round to Advance Pipeline & Execute Growth Strategy
October 18, 2022
Inside Xentria
Xentria Appoints Lead Scientific Advisor & Chief Operating Officer
August 4, 2022
Events
FSR 2022 Global Virtual Patient Summit
July 2022
Products
Xentria Shares Initial Findings of Novel Biologic XTMAB-16’s Potential to Reduce Sarcoidosis Granuloma
June 24, 2022
Events
American Thoracic Society (ATS) International Conference 2022
May 13-18, 2022
Happenings
Xentria to Present Initial Preclinical Findings of XTMAB-16 at ATS 2022 International Conference
March 8, 2022
Events
The Balancing Act Presents Behind the Mystery
December 2021
Happenings
Xentria Highlights New Episode Of Lifetime® TV’s “Behind The Mystery” Segment Of “The Balancing Act®” On Sarcoidosis
December 6, 2021
Events
WASOG/AASOG 2021: Multidisciplinary Meeting for Sarcoidosis and ILD
November 29 - December 2 2021
Events
FSR 2021 Clinical Engagement Conference
October 2nd 2021
Products
Xentria Initiates Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis
June 22, 2021
Events
FSR 2021 Virtual Patient Education Summit
June 2021
Inside Xentria
NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business
May 20, 2021
Events
Xentria Patient Focus Group: Living with Sarcoidosis
April 2021
Inside Xentria
Xentria Submits IND Application for XTMAB-16 in the Treatment of Sarcoidosis
March 3, 2021
Products
Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis
December 15, 2020